NetworkNewsBreaks Archive - Page 1554 of 2227

TuesdayMar 10, 2020 12:03 pm

NetworkNewsBreaks – Mohawk Group Holdings, Inc. (NASDAQ: MWK) Featured in ROTH Equity Research Report

Mohawk Group Holdings, Inc. (NASDAQ: MWK) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We believe Mohawk is significantly disrupting several consumer product categories using its proprietary software platform: AIMEE. Mohawk uses data from e-commerce platforms to develop products in categories where it can dominate search results, while optimizing price, marketing, and fulfillment to generate product-level contribution margins of ~10%. We believe Mohawk has demonstrated the viability of this model and see a path to profitability ahead. We resume coverage of Mohawk at Buy with a $6 PT.” To request access…

TuesdayMar 10, 2020 11:53 am

NetworkNewsBreaks – Pixelworks, Inc. (NASDAQ: PXLW) Featured in ROTH Equity Research Report

Pixelworks, Inc. (NASDAQ: PXLW) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We believe PXLW represents a differentiated investment opportunity in video display processing capabilities. We believe the Find X2 smartphones represent the first of several future OPPO smartphone models that will critically rely on PXLW’s Iris advanced video features to drive upgrade cycles. We expect PXLW’s to develop additional Tier-1 smartphone traction in the coming quarters. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Pixelworks, Inc. Pixelworks provides industry-leading content creation, video delivery…

TuesdayMar 10, 2020 11:41 am

NetworkNewsBreaks – Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Featured in Mizuho Securities Research Report

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We continue to recommend shares of CRVS based on our view that data can reset the company's valuation, and we see that visibility improving this year. The 4Q19 update call pointed to ASCO and SITC as key venues for data disclosures for ciforadenant (cifo) and CPI-006, respectively, which we believe could validate encouraging data and immuno-modulatory activity previously presented and bring clarity to the clinical path and commercial opportunity. Our FY20 EPS remains largely unchanged, now ($1.58) from…

TuesdayMar 10, 2020 11:35 am

NetworkNewsBreaks – Arcus Biosciences, Inc. (NYSE: RCUS) Featured in Mizuho Securities Research Report

Arcus Biosciences, Inc. (NYSE: RCUS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We like shares of RCUS based on the combinatorial approach to development of its immuno-oncology (I/O)-focused pipeline. The 4Q19 EPS update reaffirmed the development strategy for 2020, including catalysts for initial data for AB928+FOLFOX in mCRC (AACR) and preliminary randomization data from AB154 (anti-TIGIT) in 1st-line NSCLC. The shares have rallied this year based on interest in AB154, in our view, which is understandable following the external validation of the program via competitor advancement into Phase III, as…

TuesdayMar 10, 2020 11:26 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation (DCF and EV/Sales) to derive our $54 PT. Our assumptions include: Rhopressa: U.S. peak-sales of $162 mil in 2025. Rocklatan: U.S. peak-sales of $331 mil in 2025. DCF Assumptions: Terminal value of 5x 2028 FCF and a 11% discount rate to derive a$49 PT. EV/Sales Assumptions: 7x multiple of 2028 sales, discounted at 11% to derive a $58 PT. In our bull case scenario, we assume greater than anticipated market share of…

TuesdayMar 10, 2020 11:18 am

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “In our bull case scenario, we assume greater than expected uptake of the Xeris glucagon rescue pen. We project peak market share reaching ~60% for total U.S. peak sales of$494mn in 2029. In addition, we also apply a higher multiple of 5x in our EV/Sales methodology to account for higher growth. This translates into a $25 PT” To request access to the full report, visit http://nnw.fm/SaZ9d About Xeris Pharmaceuticals, Inc. Xeris is a specialty pharmaceutical company delivering innovative…

TuesdayMar 10, 2020 10:28 am

NetworkNewsBreaks – Choom(TM) (CSE: CHOO) (OTCQB: CHOOF) Continues Expansion of Cannabis Retail Network with 15th Alberta Location

Choom(TM) (CSE: CHOO) (OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, on Monday announced the opening of a licensed cannabis retail store in Edmonton, Alberta. The latest brick-and-mortar location is slated to open on March 13, 2020. "We look forward to welcoming the community of Edmonton as we share our unique retail experience with the opening of Choom's 15th location in Alberta," Choom CEO Corey Gillon said in the news release. "We are thrilled to continue the expansion of our cannabis retail network throughout the province." To view…

TuesdayMar 10, 2020 9:52 am

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. According to the update, the monthly subscription rate of $19.95 now includes an option of three (3) premium visits per month as well as free prescription delivery service through its subsidiaries. A virtual healthcare subsidiary, Bonum Health provides telehealth services and prescription ordering via teleconferences that are routinely conducted using smart devices. The company provides a HIPPA compliant, dynamic way for patients to access board-certified physicians from the comfort of their…

MondayMar 09, 2020 3:27 pm

NetworkNewsBreaks – INEO Tech Corp. (TSX.V: INEO) Retains Angad Capital Inc. for Advisory Services

INEO Tech (TSX.V: INEO), the developer of The Welcoming System for retailers, recently announced that it has engaged Angad Capital Inc. to deliver investor relations services, corporate strategy and capital markets advisory, subject to approval by the TSX Venture Exchange. In relation to the engagement, Angad was awarded a consulting agreement for an initial term of one year beginning March 1, 2020, for a monthly fee of C$10,000. INEO also granted Angad options to purchase 500,000 common shares in the capital of the company at a price of $0.26 each, in accordance with the company’s Stock Option Plan. The options…

MondayMar 09, 2020 12:18 pm

NetworkNewsBreaks – Global Water Resources, Inc. (NASDAQ: GWRS) Featured in ROTH Equity Research Report

Global Water Resources, Inc. (NASDAQ: GWRS) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “GWRS continues to be positioned for growth over the next several years. Permit activity supports 4%-5% organic connection growth. In addition, the recent equity offering reloads the balance sheet for continued infrastructure investment (rates) and opportunities for acquisitions. Finally, we anticipate a rate case filing by June 2020, which should add new rates to the income state potentially impacting 2H 21 and 2022. We believe GWRS is the fastest growing water utility in the US with the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks